Apimeds settles with Inscobee, clears path for merger and $100M financing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. HNGE
8. INSP
9. DOX
10. SPY

Go back to Apimeds settles with Inscobee, clears path for merger and $100M financing

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

May 5, 2026 2:07 PM EDT

Trading Expected to Resume on NYSE American on Tuesday, May 5

MATAWAN, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced a comprehensive settlement with Inscobee Inc. and Apimeds Inc. (the Inscobee Parties), resolving all outstanding disputes arising from the APUS December 1, 2025, merger with MindWave Innovations Inc. The settlement clears the path for completion of the merger transactions, effectuation of the Companys previously disclosed $100 million PIPE financing, and the advancement of Lkahi Therapeutics, Inc. as an independent biopharmaceutical company focused on the... More